English | Español
Daniel Daw | Sep 18, 2015

Study shows Jardiance reduces cardiovascular risks in patients with Type 2 diabetes
Daniel Daw | Sep 18, 2015

Bristol-Myers Squibb's Opdivo gets FDA OK for use against kidney cancer

Jamie Barrand | Sep 18, 2015

Spriva Respimat approved by FDA for maintenance treatment of asthma
Jamie Barrand | Sep 18, 2015

Proposed policies could hinder U.S. medical progress
Jamie Barrand | Sep 17, 2015

Study shows ZiNGO significantly reduces venous access pain in pediatric patients
Jamie Barrand | Sep 17, 2015

Janssen's multiple myeloma drug accepted for FDA priority review

LocalLabs News Service | Sep 10, 2015

Health Alliance Medical Plans to raise rates 11%

Trending
+ Pharmaceuticals
Patient Daily | Nov 3, 2025

Patient groups urge Congress to renew enhanced premium tax credits before open enrollment
Patient Daily | Nov 5, 2025

Riley Gaines on 340B program: ‘Blue states are using taxpayer dollars to fund unregulated child mutilation procedures’
Patient Daily | Nov 4, 2025

Philadelphia-based cardiologist: '340b is an absolute disaster that does next to nothing to help poor patients'
Patient Daily | Nov 5, 2025

Pacific Research Institute CEO on misuse of 340B funds: ‘340B was meant to help low-income patients'